RUSAN PHARMA PRIVATE LIMITED, a pharmaceutical company based in India specializing in the area of addiction treatment and pain management, recently announced that the United States Food and Drug Administration (US FDA) has granted Good Manufacturing Practice (GMP) approval for its Active Pharmaceutical Ingredient (API)